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Yi-Ching WangIn eukaryotic normal diploid cells, transcription must
be accomplished in an efficient and faithful manner.
The three nuclear RNA polymerases, transcription factors,
chromatin regulators, and signaling pathways are among
the key components that control gene expression. The mo-
lecular mechanisms by which these regulators control ex-
pression of individual genes have been studied extensively
and are reviewed elsewhere [1,2]. Recently, various detect-
ive techniques and genome-wide profiling have shown that
transcriptional deregulation including errors during RNA
editing and epigenetic disorders gives rise to several signifi-
cant human diseases including various cancers, neuron dis-
order, psychosis, and cardiovascular diseases [3,4].
In this issue of Cell & Bioscience, we have provided
some evidences that deregulation of ribosomal gene
(rDNA) transcription is a feature of cancer and other hu-
man disorders [5]. Critical issues with regard to how RNA
editing crosstalks with other transcript-associated events
to underpin regulated gene expression are discussed [6].
In addition, some new insights into the role of non-
histone methylation and DNA demethylation in cancer
progression are summarized [7]. We also highlight the
current status of transcriptional and post-translational
regulation of the DNA methyltransferase (DNMT) expres-
sion and activity with a focus on dysregulation involved in
tumorigenesis [8].
Diesch et al. presented in their review entitled “Pertur-
bations at the ribosomal genes loci are at the centre of cel-
lular dysfunction and human disease” multiple aspects of
rDNA functions. These functions not only include the re-
lationship between RNA polymerase I (Pol I) transcription
and proliferative property, but also the role of Pol I tran-
scription in mediating heterochromatin structure and func-
tion, global gene expression and DNA damage response.
Their review casts nucleolus as a central hub for coordin-
ation of stress responses. Notably, deregulation of Pol I
transcription is required for malignant transformation andCorrespondence: ycw5798@mail.ncku.edu.tw
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unless otherwise stated.can be targeted with small molecule inhibitors to treat
cancer [5].
Liu and associates summarized current technological
advances in genomics methods in the study of functional
impact of RNA editing and the adenosine deaminse acting
on RNA (ADAR) family of enzymes on the regulation of
gene expression in their review. In the past few years, re-
search in the field of A-to-I RNA editing has been acceler-
ated dramatically by the development of next generation
sequencing (NGS) technology, which has expanded the
landscape of RNA editome as well as our understanding
of its regulation. Liu et al. reviewed the principles and
techniques of the recent NGS-based studies that link
RNA editing to various aspects of post-transcriptional
RNA processing, alternative splicing, transcript stability
and localization. Their review also pointed out the possi-
bility that NGS data may be applied for further interroga-
tion of the “RNA editing codes”, at which functional
outcome could be explored in a global manner [6].
Baxter and colleagues systematically reviewed the alter-
ations and mechanisms of DNA methylation and histone
modifications in cancer. They described major findings on
DNA demethylation resulting from replication-dependent
passive dilution of 5-methylcytosine and active DNA de-
methylation catalyzed by Ten-eleven translocation (TET)
family proteins. Baxter et al. emphasized on the transcrip-
tional activity of HIF-α modulated by the histone methyl-
transferase G9a mediated methylation of non-histone
proteins such as Reptin and Pontin in hypoxia. This re-
view provides useful information for future therapeutic
potentials by targeting the methylation of non-histone
proteins under hypoxic conditions [7].
Lin and Wang evaluated in their review entitled “Dysreg-
ulated transcriptional and post-translational control of
DNA methyltrasferases in cancer” the deregulation mecha-
nisms of DNMTs. They focused on the transcriptional
repression controls on DNMT genes by p53, RB and
FOXO3a transcriptional regulators and corepressors. Inter-
estingly, overexpressed MDM2 may induce DNMT1,
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sions of miRNAs 29 s, 143, 148a and 152 are associated
with overexpression of DNMTs in various cancers. In this
review, several important post-translational modifications
including acetylation and phosphorylation in the control
of protein stability and activity of the DNMTs especially
DNMT1 are discussed [8].
Due to the broad nature of transcriptional regulation
and its misregulation in diseases, it is not our intention to
cover all major aspects of this active research area in this
single issue. However, we hope that these articles provide
readers with insightful information of how alterations of
Pol I transcription, RNA editing, non-histone methylation,
and DNA methylation regulations may be used as disease
biomarkers and for targeted therapies.
Received: 28 July 2014 Accepted: 28 July 2014
Published: 19 August 2014
References
1. Lee TI, Young RA: Transcriptional regulation and its misregulation in
disease. Cell 2013, 152:1237–1251.
2. Misteli T: Higher-order genome organization in human disease.
Cold Spring Harb Perspect Biol 2010, 2:a000794.
3. Farajollahi S, Maas S: Molecular diversity through RNA editing: a
balancing act. Trends Genet 2010, 26:221–230.
4. Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and
prospects for epigenetic therapy. Nature 2004, 429:457–463.
5. Diesch J, Hannan RD, Sanij E: Perturbations at the ribosomal genes loci
are at the centre of cellular dysfunction and human disease.
Cell Bioscience 2014.
6. Liu H, Ma CP, Chen YT, Schuyler SC, Chang KP, Tan BCM: Functional impact
of RNA editing and ADARs on regulation of gene expression:
perspectives from deep sequencing studies. Cell Bioscience 2014.
7. Baxter E, Windloch K, Gannon F, Lee JS: Epigenetic regulation in cancer
progression. Cell Bioscience 2014,
8. Lin RK, Wang YC: Dysregulated transcriptional and post-translational
control of DNA methyltrasferases in cancer. Cell Bioscience 2014.
doi:10.1186/2045-3701-4-42
Cite this article as: Wang: Thematic series: transcriptional regulation
and disease. Cell & Bioscience 2014 4:42.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
